Pyruvate is a key intermediate in energy metabolism, but the renal cortical pyruvate has been depleted in mice subjected to ischemia or glycerol-induced AKI; pyruvate administration confers a marked protection against AKI by increasing anti-inflammatory IL-10 and HO-1 levels [33,34]. Here, IL10 is linked to ischemia.